We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.2B
AUM Growth
-$48.8M
Cap. Flow
-$39.7M
Cap. Flow %
-3.3%
Top 10 Hldgs %
45.64%
Holding
136
New
5
Increased
35
Reduced
40
Closed
3

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$2.35M
2
TMO icon
Thermo Fisher Scientific
TMO
+$2.02M
3
CI icon
Cigna
CI
+$1.29M
4
PGNY icon
Progyny
PGNY
+$845K
5
KFY icon
Korn Ferry
KFY
+$627K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$20M
2
AMZN icon
Amazon
AMZN
+$11.6M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.35M
4
LH icon
Labcorp
LH
+$2.27M
5
PEP icon
PepsiCo
PEP
+$2M

Sector Composition

Rank Sector Weight
1 Technology 44.34%
2 Healthcare 15.66%
3 Communication Services 15.45%
4 Consumer Discretionary 10.79%
5 Financials 10.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBA icon
76
Ambarella
AMBA
$3.04B
$1.87M 0.16%
35,267
MOH icon
77
Molina Healthcare
MOH
$10.4B
$1.81M 0.15%
5,519
+24
+0.4% +$7.55K
SAIC icon
78
Saic
SAIC
$4.95B
$1.78M 0.15%
16,852
+1,880
+13% +$216K
FFIV icon
79
F5
FFIV
$22B
$1.7M 0.14%
10,525
CTRA
80
DELISTED
Coterra Energy
CTRA
$1.66M 0.14%
61,541
BIIB icon
81
Biogen
BIIB
$30.9B
$1.66M 0.14%
6,440
+250
+4% +$66.9K
JKHY icon
82
Jack Henry & Associates
JKHY
$11.4B
$1.64M 0.14%
10,875
BIO icon
83
Bio-Rad Laboratories Class A
BIO
$8.76B
$1.61M 0.13%
4,489
-401
-8% -$155K
SIMO icon
84
Silicon Motion
SIMO
$7.11B
$1.58M 0.13%
30,810
-3,000
-9% -$171K
MRK icon
85
Merck
MRK
$322B
$1.55M 0.13%
15,058
-8,092
-35% -$872K
SYK icon
86
Stryker
SYK
$135B
$1.5M 0.12%
5,482
INCY icon
87
Incyte
INCY
$25.4B
$1.48M 0.12%
25,685
-1,966
-7% -$124K
TSLA icon
88
Tesla
TSLA
$1.18T
$1.46M 0.12%
5,817
MRNA icon
89
Moderna
MRNA
$21.6B
$1.44M 0.12%
13,898
+817
+6% +$91.1K
JNJ icon
90
Johnson & Johnson
JNJ
$640B
$1.36M 0.11%
8,739
+200
+2% +$33K
PCTY icon
91
Paylocity
PCTY
$7.75B
$1.31M 0.11%
7,220
SEDG icon
92
SolarEdge
SEDG
$2.37B
$1.23M 0.1%
9,509
+612
+7% +$117K
FTNT icon
93
Fortinet
FTNT
$112B
$1.22M 0.1%
20,800
IBM icon
94
IBM
IBM
$213B
$1.11M 0.09%
7,885
-376
-5% -$53.5K
KAI icon
95
Kadant
KAI
$3.58B
$1.05M 0.09%
4,668
CVS icon
96
CVS Health
CVS
$135B
$1.05M 0.09%
15,000
-3,200
-18% -$227K
CNC icon
97
Centene
CNC
$30.5B
$1.03M 0.09%
15,000
-4,900
-25% -$326K
ILMN icon
98
Illumina
ILMN
$29.5B
$981K 0.08%
7,347
-902
-11% -$148K
KFRC icon
99
Kforce
KFRC
$1.05B
$910K 0.08%
15,255
+340
+2% +$20.7K
BBSI icon
100
Barrett Business Services
BBSI
$1.01B
$903K 0.08%
40,008

Similar funds

Oak Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Oak Associates held 136 positions worth $1.2B, down 3.9% from $1.25B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Oak Associates withdrew a net $39.7M in Q3 2023, closing 3 positions and reducing 40 holdings. Its most notable exit was AbbVie, an estimated $2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Thermo Fisher Scientific worth $1.92M.

  • Oak Associates's largest Q3 2023 buy was Thermo Fisher Scientific: 3,791 shares worth $1.92M.
  • Oak Associates added most to PayPal in Q3 2023, an estimated $2.35M increase.
  • Oak Associates's biggest Q3 2023 reduction was Apple, cutting an estimated $20M.
  • Oak Associates fully exited AbbVie in Q3 2023, selling an estimated $2M.
  • Oak Associates's ten largest holdings make up 46% of its $1.2B portfolio in Q3 2023.
  • Oak Associates opened 5 new positions and closed 3 in Q3 2023.
  • Oak Associates's portfolio value fell 3.9% quarter-over-quarter to $1.2B.

Based on Oak Associates's 13F filing for Q3 2023, filed 13 Nov 2023.